BioHealth News Archive
The Real Threat Of Identity Theft Is In Your Medical Records, Not Credit Cards
The 2017 holiday season has been complicated by data breaches that have plagued consumers all year long, such as the massive Equifax hack. As…
Read More
HHS selects 15 tech leaders to discuss healthcare innovation, investment – Health Data Management
The Department of Health and Human Services has picked 15 technology leaders from the private sector with which to initiate a year-long dialogue on…
Read More
REGENXBIO and Rocket Pharmaceuticals Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary…
Read More
Huge Breakthrough, Huge Controversy: Researcher in China Edits Human Embryo Genes | BioSpace
He Jiankui, a researcher in Shenzhen, China, claims he utilized CRISPR-Cas9 gene editing to alter the DNA of embryos for seven couples. {iframe}https://www.biospace.com/article/huge-breakthrough-huge-controversy-researcher-in-china-edits-human-embryo-genes/{/iframe}
Read More
Legal Issues for Early Stage Companies
Thursday, December 13, 2018 Business formation and governance Advisory board vs board of directors Equity incentive plans Non-disclosure agreements (with potential co-owners/joint ventures/investors and…
Read More
University System of Maryland: Maryland’s Most Powerful Economic Engine – USM
The University System of Maryland (USM) is Maryland's public higher education system, consisting of 11 degree-granting universities, two regional higher education centers and one…
Read More
Protenus Co-Founders Named to Rising Stars List
Becker's Healthcare is pleased to honor 90 healthcare leaders under 40 years old as rising stars in the industry. {iframe}https://www.beckershospitalreview.com/lists/rising-stars-88-healthcare-leaders-under-40.html?utm_campaign=Q4%20Social%20Selling&utm_content=79942286&utm_medium=social&utm_source=linkedin{/iframe}
Read More
Capital Region Blueprint for Regional Mobility
Today, the Greater Washington Partnership unveiled the Blueprint For Regional Mobility, the first ever CEO-driven comprehensive strategy that binds the Capital Region and better…
Read More
An Illustrated Subway Map of Human Anatomy
What comes to mind when you think about your body? Most people might imagine an intricate network of blood vessels or the complex neural…
Read More
Emergent BioSolutions Success Story – Maryland is Open for Business
With preparedness solutions that address emerging infectious diseases to chemical and biological threats, protecting and enhancing lives is at the heart of everything Emergent BioSolutions…
Read More
PathSensors Secures 5-year Department of Defense Contract for Building Protection | PathSensors
PathSensors, Inc., a rapidly growing, Baltimore-based biotechnology company focused on delivering pathogen detection solutions, announced today that it has been awarded a $7.2 million…
Read More
Adaptive Phage Therapeutics named in reporting citing Top 36 Startups Which Could Change the World – CB Insights Research
As stated by Josh Wolfe, co-founder and managing partner at Lux Capital, “the gap between ‘sci-fi’ — that which was once imagined — and…
Read More
Rexahn Pharmaceuticals names Doug Swirsky new CEO – Washington Business Journal
The new chief executive had joined the company in January — after selling his last biotech company for several million dollars. {iframe}https://www.bizjournals.com/washington/news/2018/11/21/not-business-as-usual-rockville-biopharma-s-new.html{/iframe}
Read More
Emergent BioSolutions and Valneva’s Zika vaccine turns up positive early-phase data – FiercePharma
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer…
Read More
THE ENTREPRENEURS REPORT: Private Company Financing Trends – Q3 2018
Market conditions for venture funding remained very strong in the third quarter of 2018. Deal size and pre-money valuations across all equity rounds decreased…
Read More